EvoSci: A Bio-Inspired Multi-Agent Framework for the Evolution of Scientific Discovery

Large Language Models (LLMs) have demonstrated potential in automating scientific ideation, yet current approaches relying on iterative prompting or complex multi-agent architectures often suffer from hallucination or computational inefficiency. A critical bottleneck in applying Reinforcement Learning (RL) to this open-ended domain is reward hacking -- where models exploit imperfect evaluation proxies to maximize scores without producing genuine scientific innovation. To address these limitations, we propose an RL framework explicitly tailored for high-quality scientific idea generation. We propose the first multi-agent reward function designed to serve as a judge, decoupling methodological validation from implementation details while providing strict binary rewards that are robust to reward hacking. To effectively optimize against this sparse signal, we utilize an unbiased variant of Group Relative Policy Optimization to mitigate artificial length bias. We grounded our training in ICLR-320, a curated dataset of problem-solution pairs extracted from ICLR 2024 proceedings. Experiments demonstrate that our framework significantly outperforms state-of-the-art baselines across expert-evaluated metrics of novelty, feasibility, and effectiveness.

LLM-empowered multi-agent systems offer new potential to accelerate scientific discovery by generating novel research ideas. However, existing methods typically coordinate agents through temporary texts, such as drafts or chat logs; it is difficult to pinpoint the weaknesses in the generated ideas and how the agents refine them. To this end, we introduce \textbf{Evolving Idea Graphs} (EIG), a graph-based multi-agent scientific ideation framework that can generate high-performance research ideas across various benchmark-native metrics, such as novelty, feasibility, and clarity. Instead of coordinating solely through texts, EIG represents a partially formed proposal as an evolving idea graph, where nodes capture scientific claims and edges encode relations (e.g., support and conflict), enabling unresolved weaknesses to remain identifiable throughout the idea evolving process. Specifically, a learned two-head controller operates over the evolving graph to guide the ideation: one head selects graph edits for agents to execute, while the other decides when the graph is ready for commit as final proposal synthesis. On AI Idea Bench 2025 and LiveIdeaBench, EIG outperforms all compared systems on both automatic benchmark scores and blind expert ratings. Ablations further show that explicit graph state provides the main performance gains, and learned edit-and-commit control adds consistent improvements.

Scientific agents contribute to hypothesis discovery by synthesizing evidence, assessing proposals, and developing new explanations. Recent systems combine scientific agents with evolutionary search through critique, comparison, and revision. However, how different forms of agent collaboration affect hypothesis quality remains an open question. Answering this question requires separating the effects of agents' scientific capabilities from those of their collaboration. A framework must therefore preserve agents' scientific roles and support rules for combining, revising, and retaining hypotheses. Building on this view, we introduce HypoEvolve, which makes collaboration explicit through successive updates to a hypothesis population. Specifically, we propose a generational genetic algorithm to coordinate specialized large language model (LLM) agents that integrate mechanistic arguments, reconsider assumptions, and assess evidence and testability. Each generation specifies how scientific judgments and new proposals reshape the population, making collaboration effects on hypothesis quality directly testable. Moreover, we design our evaluation around scientifically meaningful hypotheses that explain how a proposed intervention could work. Drug repurposing links these explanations to target-level biological claims assessed against external evidence. Specifically, we adapt DepMap and Open Targets into complementary external measures grounded in experimental, genetic, and clinical evidence. Across 34 cancer types, HypoEvolve achieves the highest scores against six baselines on both measures. DepMap selectivity reaches 0.171, versus 0.115 for the strongest baseline. Gains over single-pass generation also generalize to held-out cancer types. HypoEvolve advances a vision of autonomous science in which AI research teams achieve a capacity for discovery beyond that of individual models.